Franklin Street Advisors Inc. NC Buys 15,044 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Franklin Street Advisors Inc. NC raised its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 62.0% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 39,299 shares of the medical equipment provider's stock after buying an additional 15,044 shares during the quarter. Intuitive Surgical accounts for 1.4% of Franklin Street Advisors Inc. NC's portfolio, making the stock its 28th largest position. Franklin Street Advisors Inc. NC's holdings in Intuitive Surgical were worth $19,464,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently bought and sold shares of the company. Trueblood Wealth Management LLC lifted its position in shares of Intuitive Surgical by 13.0% in the first quarter. Trueblood Wealth Management LLC now owns 1,279 shares of the medical equipment provider's stock worth $633,000 after purchasing an additional 147 shares in the last quarter. Handelsbanken Fonder AB lifted its position in shares of Intuitive Surgical by 4.5% in the first quarter. Handelsbanken Fonder AB now owns 267,186 shares of the medical equipment provider's stock worth $132,329,000 after purchasing an additional 11,443 shares in the last quarter. Petredis Investment Advisors LLC lifted its position in shares of Intuitive Surgical by 1.1% in the first quarter. Petredis Investment Advisors LLC now owns 11,716 shares of the medical equipment provider's stock worth $5,803,000 after purchasing an additional 122 shares in the last quarter. Sanibel Captiva Trust Company Inc. lifted its position in shares of Intuitive Surgical by 102.2% in the first quarter. Sanibel Captiva Trust Company Inc. now owns 1,880 shares of the medical equipment provider's stock worth $931,000 after purchasing an additional 950 shares in the last quarter. Finally, Avanza Fonder AB lifted its position in shares of Intuitive Surgical by 1.3% in the first quarter. Avanza Fonder AB now owns 36,889 shares of the medical equipment provider's stock worth $18,705,000 after purchasing an additional 456 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on ISRG. Truist Financial reduced their price target on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a research report on Wednesday, April 23rd. Piper Sandler cut their price objective on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 23rd. Erste Group Bank raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Thursday, June 5th. Citigroup reaffirmed a "buy" rating and set a $650.00 price objective (up previously from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Finally, Deutsche Bank Aktiengesellschaft lowered shares of Intuitive Surgical from a "hold" rating to a "sell" rating and cut their price objective for the company from $515.00 to $440.00 in a research report on Monday. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $588.95.

Intuitive Surgical Stock Down 1.8%

ISRG stock traded down $9.41 during midday trading on Thursday, reaching $513.00. The stock had a trading volume of 2,390,381 shares, compared to its average volume of 1,668,728. The business has a fifty day simple moving average of $525.48 and a two-hundred day simple moving average of $538.67. The firm has a market cap of $183.87 billion, a price-to-earnings ratio of 80.03, a PEG ratio of 5.85 and a beta of 1.67. Intuitive Surgical, Inc. has a twelve month low of $413.82 and a twelve month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. The firm had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same period last year, the company earned $1.50 earnings per share. On average, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, SVP Mark Brosius sold 216 shares of the business's stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $563.11, for a total transaction of $121,631.76. Following the completion of the transaction, the senior vice president now directly owns 907 shares in the company, valued at approximately $510,740.77. The trade was a 19.23% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Robert Desantis sold 188 shares of the business's stock in a transaction dated Monday, April 28th. The stock was sold at an average price of $515.91, for a total value of $96,991.08. Following the transaction, the executive vice president now owns 5,224 shares of the company's stock, valued at $2,695,113.84. The trade was a 3.47% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 4,998 shares of company stock worth $2,611,577 over the last three months. 0.70% of the stock is currently owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.